HIV & Other Emerging Viruses affecting Afro-Asian Continents
Due to the widespread infection of HCV and demand for these enhanced treatments, multiple estimates forecast the global market for HCV treatment will reach $20 billion yearly before the decade's get over.
Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis A is an intense irresistible infection of the liver caused by the hepatitis A virus. Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both intense and chronic infections. HCV is spread primarily by blood-to-blood contact connected with intravenous drug use, inadequately cleaned therapeutic gear, and transfusions.
- HIV Associated Diseases
- HIV and retroviral transmission and prevention
- Influenza Viruses
- Viral meningitis
- Filoviruses-Ebola virus & Westnile Viruses
- Herpes & Pox Viruses
- Virus Receptors & Viral Entry
- Oncovirus.
- Polio virus
- Severe acute respiratory syndrome
- Corona Viruses
- Swine flu outbreak,Prevention & Treatment
- HPV & Other Sexually Transmitted Diseases
Related Conference of HIV & Other Emerging Viruses affecting Afro-Asian Continents
HIV & Other Emerging Viruses affecting Afro-Asian Continents Conference Speakers
Recommended Sessions
- Agriculture and plant virology
- Clinical & Neuro Virology
- Current Focus in Virology Research
- Drug discovery program
- HIV & Other Emerging Viruses affecting Afro-Asian Continents
- Host Immune Defences & Immunotherapy
- Pediatric Viral Diseases
- Recent Advances in Viral Therapy
- Therapeutic Approaches & Targets for Viral Infections
- Tumour Virology and Immunology
- Vaccines and Viral Vectors
- Veterinary Virology
- Viral Evolution & General Virology
- Viral hepatitis